Hepatocellular carcinoma

View PDF

Overview 
Theory 
Diagnosis 
Management 
Follow up 
Resources 

International guidelines

Rest of the world

NCCN clinical practice guidelines in oncology: management of immunotherapy-related toxicities[138]

Published by:National Comprehensive Cancer Network

Last published:2024

Systemic therapy for advanced hepatocellular carcinoma[107]

Published by:American Society of Clinical Oncology

Last published:2024

NCCN clinical practice guidelines in oncology: hepatocellular carcinoma[63]

Published by:National Comprehensive Cancer Network

Last published:2024

Practice parameter for selective internal radiation therapy (SIRT) or radioembolization for treatment of liver malignancies[137]

Published by:American Brachytherapy Society; Society of Nuclear Medicine and Molecular Imaging; Society of Interventional Radiology; American College of Nuclear Medicine; American College of Radiology; American Radium Society

Last published:2024

ACR appropriateness criteria: abnormal liver function tests[83]

Published by:American College of Radiology

Last published:2023

AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma[3]

Published by:American Association for the Study of Liver Diseases

Last published:2023

Management of toxicities from immunotherapy: ESMO clinical practice guideline for diagnosis, treatment and follow-up[139]

Published by:European Society for Medical Oncology

Last published:2022

ACR appropriateness criteria: management of liver cancer[91]

Published by:American College of Radiology

Last published:2022

AGA clinical practice guideline on systemic therapy for hepatocellular carcinoma[106]

Published by:American Gastroenterological Association

Last published:2022

External beam radiation therapy for primary liver cancers[136]

Published by:American Society for Radiation Oncology

Last published:2021